학술논문
1545P - Brigatinib in ALK TKI-pretreated ALK+ metastatic non-small cell lung cancer (mNSCLC): The use via expanded access to brigatinib (UVEA-Brig) study
Document Type
Abstract
Author
Source
In Annals of Oncology October 2019 30 Supplement 5:v636-v636
Subject
Language
ISSN
0923-7534